StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Benitec Biopharma's price to sales ratio was 429.5× on Jan 31, 2024, against 48.9× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 2024429.5×−64.2
2023Dec 29, 2023493.7×+405.4
2022Oct 31, 202288.3×+49.9
2020Jul 31, 202038.4×−2.7
2019Dec 31, 201941.1×–

More Benitec Biopharma figures

See a number that looks wrong?